B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 34, Issue 3, Pages (March 2011)
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
by Juan C. Rodríguez-Alba, Miguel E
Volume 31, Issue 1, Pages (July 2009)
Volume 36, Issue 6, Pages (June 2012)
Volume 30, Issue 4, Pages (April 2009)
Volume 31, Issue 2, Pages (August 2009)
Volume 40, Issue 2, Pages (February 2014)
Volume 11, Issue 12, Pages (June 2015)
Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Critical Regulator of B Cell Homeostasis in Secondary Lymphoid Organs  Ping Xie, Laura L. Stunz,
Volume 26, Issue 1, Pages (January 2007)
Volume 36, Issue 5, Pages (May 2012)
CD19 controls Toll-like receptor 9 responses in human B cells
Volume 38, Issue 1, Pages (January 2013)
Volume 38, Issue 3, Pages (March 2013)
Volume 36, Issue 5, Pages (May 2012)
Volume 39, Issue 1, Pages (July 2013)
Volume 43, Issue 6, Pages (December 2015)
Volume 4, Issue 4, Pages (October 2008)
Volume 22, Issue 13, Pages (March 2018)
Volume 46, Issue 6, Pages e4 (June 2017)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 3, Pages (March 2006)
Volume 36, Issue 5, Pages (May 2012)
Volume 24, Issue 5, Pages (May 2006)
Volume 25, Issue 4, Pages (October 2006)
Volume 26, Issue 5, Pages (May 2007)
Volume 34, Issue 5, Pages (May 2011)
Volume 33, Issue 1, Pages (July 2010)
Volume 32, Issue 3, Pages (March 2010)
Volume 45, Issue 1, Pages (July 2016)
Volume 125, Issue 4, Pages (May 2006)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 34, Issue 5, Pages (May 2011)
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Volume 36, Issue 3, Pages (March 2012)
Volume 29, Issue 2, Pages (August 2008)
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 38, Issue 6, Pages (June 2013)
Novel Role of the Ras Cascade in Memory B Cell Response
Volume 25, Issue 5, Pages (November 2006)
Volume 43, Issue 6, Pages (December 2015)
Volume 29, Issue 1, Pages (July 2008)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 36, Issue 6, Pages (June 2012)
Volume 22, Issue 2, Pages (February 2005)
Volume 27, Issue 2, Pages (August 2007)
Volume 37, Issue 5, Pages (November 2012)
Volume 28, Issue 4, Pages (April 2008)
Volume 38, Issue 3, Pages (March 2013)
Volume 38, Issue 3, Pages (March 2013)
Volume 32, Issue 1, Pages (January 2010)
Volume 40, Issue 3, Pages (March 2014)
Volume 35, Issue 2, Pages (August 2011)
Volume 25, Issue 1, Pages (July 2006)
Volume 37, Issue 5, Pages (November 2012)
LAT Links the Pre-BCR to Calcium Signaling
Volume 32, Issue 2, Pages (February 2010)
Volume 42, Issue 4, Pages (April 2015)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 7, Issue 2, Pages (August 1997)
Volume 39, Issue 3, Pages (August 2010)
Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation  Shigeru Iwata, MD, PhD, Kunihiro Yamaoka,
Volume 28, Issue 5, Pages (May 2008)
Volume 27, Issue 4, Pages (October 2007)
Volume 31, Issue 6, Pages (December 2009)
Volume 31, Issue 5, Pages (November 2009)
Volume 23, Issue 8, Pages (May 2018)
Volume 28, Issue 1, Pages (January 2008)
Presentation transcript:

B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian Weisel, Mark J. Shlomchik  Immunity  Volume 48, Issue 2, Pages 313-326.e5 (February 2018) DOI: 10.1016/j.immuni.2018.01.008 Copyright © 2018 Elsevier Inc. Terms and Conditions

Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 AKT and ERK Pathways Are Dampened in GC B Cells Stimulated by CD40 Signals (A) Splenocytes from day 14 NP-CGG-immunized B1-8i mice were stimulated with anti-CD40 antibody or PBS (Control) for 20 min and stained for p-AKT (S473) and p-S6 (S235/236). Live Ig-lambda+ GC B cells (PNA+) and non-GC B cells (PNA−) were gated. Histograms show representative examples of at least three independent experiments; spleen cell pools from two mice were tested in each experiment. (B) Magnetic bead-purified naive B cells and GC B cells were stimulated with anti-CD40 antibody for 0, 5, and 20 min, and cells were then harvested for western blot. Shown is one experiment representative of three independent experiments. (C) GC B cells were stimulated as described in (A) and were gated on LZ and DZ to compared p-S6. Data represent one of three independent experiments. (D and E) Splenocytes from NP-CGG-immunized B1-8i mice were stimulated with anti-CD40 antibody for 0, 5, 30, 60 min. The localization of Foxo1 was examined by Amnis Imagestream cytometry. Two independent experiments were performed with cells pooled from two to three mice in each experiment. (D) Representative images of 30 min stimulated non-GC B cells and GC B cells captured by the Imagestream. Object number is shown in BF (Bright field) picture and similarity score is shown in merged picture (Foxo1/DAPI). (E) Time course showing the fraction of cells with nuclear Foxo1 (high Foxo1/DAPI similarity score). ∗p ≤ 0.05. See also Figure S1. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 2 CD40 Signals Specifically Activate the NF-κB Pathway (A) Magnetic bead-purified naive B cells and GC B cells were stimulated with anti-CD40 antibody for different time spans. Cell lysates were examined by western blot. Shown is one experiment representative of three independent experiments. Cells were purified from three or four mice in each experiment. (B–E) Splenocytes from immunized B1-8i mice were stimulated with anti-CD40 antibody or PBS (Control) for 30 min and localization of NF-κB subunits P65 (B, C) and c-Rel (D, E) was examined by Imagestream. (B and D) Representative images of GC B cells; (C and E) P65/DAPI and c-Rel/DAPI similarity score from non-GC B cells and GC B cells are plotted, R4 gate represents cells with P65 (C) or c-Rel (E) in the nucleus (high similarity score). Three independent experiments were performed with similar results and similar results were observed in both B1-8i and MEG mouse models. (F) Total B cells from immunized MEG mice were cultured with CD40 antibody or PBS (Control) for 4 hr. IRF4 expression was examined by flow cytometry, gated on naive or GC B cells. Three independent experiments were performed. See also Figure S1. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 3 BCR Signals Selectively Induce Transient Activation of Syk and AKT in GC B Cells (A) Total splenocytes pooled from two immunized MEG mice were stimulated with goat anti-IgM for different time periods. Cells were fixed, permeabilized, and stained for p-Syk (Y352), p-Btk (Y223), and p-AKT (S473). Live Ig-lambda+ GC B cells (PNA+) and non-GC B cells (PNA−) were gated. (B and C) Western blots were performed with bead-purified MEG naive and GC B cells stimulated with anti-IgM antibody for different durations. Quantitation of western blot data are shown in (C) with signals normalized to actin and further normalized to naive B cells at time 0 giving a value of 1. (D and E) Splenocytes from immunized B1-8i mice were stimulated with NP-Ficoll or PBS (Control) for 5 min. NFAT nuclear translocation was examined by Imagestream analysis. Representative images are shown in (D) and statistical analysis is shown in (E). R4 gates represent cells with nuclear NFAT translocation (high NFAT/DAPI similarity score). Data are representative results from one of three independent experiments with statistical analysis for all experiments. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 4 BCR Signals Efficiently Phosphorylate and Inactivate Foxo1 through the PI3K-AKT Pathway in GC B Cells (A) Magnetic bead-purified naive and GC B cells were stimulated with anti-IgM antibody for indicated time spans, harvested, and examined by western blot. Data are from one representative experiment of three independent experiments. Cells were purified from three to four MEG mice in each experiment. (B) Quantitation of western blot data in (A). Signal was normalized to actin and further normalized to naive B cells at time 0, giving a value of 1. (C and D) Total splenocytes from MEG mice were stimulated with anti-IgM antibody for 0, 2, 5, 10, 20, 30 min. Localization of Foxo1 was examined by Imagestream. Two independent experiments were performed. Cells were pooled from 2 to 3 mice in each experiment. (C) Representative images of Non-GC B cells and GC B cells stimulated for 0 (Control) and 5 minutes; (D) quantitation of cells with Foxo1 in the nucleus based on Foxo1/DAPI similarity score (mean ± SD). (E and F) Splenocytes from immunized MEG mice were treated with or without 5 μM Syk inhibitor (BAY61-3606), 10 μM PI3K inhibitor (Ly294002), or 5 μM AKT1/2 kinase inhibitor for 30 min and then stimulated with anti-IgM antibody for 5 min. Localization of Foxo1 was examined by Amnis Imagestream. Two independent experiments were performed, and splenocytes were pooled from two to three mice in each experiment. (E) Representative images of GC B cells with Foxo1/DAPI similarity score shown in the merged picture; (F) Foxo1/DAPI similarity score is compared between control (DMSO treated with no stimulation) and treated cells. R5 gates represent cells with Foxo1 in nucleus (high Foxo1/DAPI similarity score). Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 5 Syk Signaling Is Important in Maintaining the GC Light Zone through Inactivation of Foxo1 and Is Required for GC Maintenance (A) Time line illustration of tamoxifen (Tam) treatment for NP-CGG-immunized Syk+/+ hCD20TamCre and Sykfl/fl hCD20TamCre mice. Mice were immunized with NP-CGG and given one dose of tamoxifen orally on day 8 post immunization and analyzed on day 11 (3 days post tamoxifen); for 4-day tamoxifen treatment, tamoxifen was given on day 8 and day 10 post immunization and mice were analyzed on day 12. (B) Mice were analyzed by flow cytometry for Syk expression levels in naive and GC B cells 3 days post tamoxifen treatment. Shown is one representative histogram of Syk staining and statistical data represent seven mice from two independent experiments. (C) Splenocytes from (A) were analyzed by flow cytometry. GC B cells were gated as B220+PNA+CD95+ cells. At least three independent experiments were performed with total of 10 to 13 mice from each group tested (mean ± SD). ns, not significant; ∗∗∗∗p ≤ 0.0001. (D) Splenocytes from (A) (3 Day Tam) were stimulated with 20 μg/mL anti-IgM antibody for 5 min, IgM GC B cells were gated and analyzed for p-Foxo by flow cytometry. Shown are representative histograms for three independent experiments. See also Figure S2B for statistical analysis. (E and F) Light zone (LZ) and dark zone (DZ) GC B cells from (A) (3 Day Tam) were identified by CD86 and CXCR4 staining. (E) Representative flow cytometry analysis of GC B cells; (F) quantitation of flow cytometry data as the ratio of cells in the DZ to LZ per the gating in (E) (mean ± SD, n = 10 for each group). (G and H) Spleen cryosections from (A) (3 Day Tam) were analyzed by immunofluorescent staining for GC (IgD and PNA) and light zone (CR1). (G) Representative images; (H) statistical analysis of the percentage of LZ area in the GC (mean ± SD). Each dot represents one GC. 3 to 5 typical GC from one spleen, and 6 to 8 mice in each group from 3 independent experiments were analyzed. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001. See also Figure S2. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 6 BCR and CD40 Signals Synergistically Induce c-Myc and p-S6 in GC B Cells (A) Naive and GC B cells were purified from MEG mice and cultured with indicated stimuli for 2 hr (unstimulated as Control), harvested, and examined by western blot for c-Myc and p-S6 (S235/236). Data are results from one of three independent experiments. Cells were pooled from three to four mice in each experiment. (B) Quantitation of (A): c-Myc/actin ratio and p-S6/actin ratios were normalized to naive B cells, with Control given a value of 1. Mean + SD; asterisk (∗) on the bar shows significance compared to Control. (C) Total B cells were purified from immunized B1-8i mice and stimulated in vitro as indicated for 2 hr (unstimulated as Control). Cells were then fixed, permeabilized, and examined by flow cytometry for c-Myc expression. One representative example of five independent experiments is shown. Similar results were obtained by using 2.5 μg/mL biotinylated CD40 antibody preincubated with streptavidin. (D and E) Day 10 NP-CGG-immunized IgMi mice were injected intravenously with goat anti-IgM or goat IgG isotype control and sacrificed 4 hr after injection. Splenocytes were analyzed by flow cytometry for c-Myc expression in naive and GC B cells. (D) Representative flow cytometry data. (E) Quantitation and statistical analysis of c-Mychi cells among naive or GC B cells from flow cytometry data. Control: n = 8, α-IgM: n = 10; each dot represents a single mouse with mean ± SD. (F) LZ and DZ distribution of GC B cells from (D) was analyzed by flow cytometry based on CD86 and CXCR4 expression (mean ± SD). ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001. See also Figure S3. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 7 BCR Signals Are Required for Optimal c-Myc Induction in GC B Cells In Vivo Syk+/+ hCD20TamCre and Sykfl/fl hCD20TamCre mice were immunized with NP-CGG. One dose of tamoxifen was administrated orally on day 8 post immunization. Mice at day 11 post immunization were injected intravenously with 50 μg of anti-CD40 antibody (FGK) or isotype control (rat IgG2a) and analyzed 4 hr after injection. c-Myc expression was examined by flow cytometry and cells were gated on naive B cells (B220+CD38+PNA−) and GC B cells (B220+CD38−PNA+). Representative flow cytometry data are shown in (A) and statistical analysis is shown in (B). Data represent three independent experiments with total of 5 to 9 mice from each treatment group (mean ± SD). ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001. See also Figure S4. Immunity 2018 48, 313-326.e5DOI: (10.1016/j.immuni.2018.01.008) Copyright © 2018 Elsevier Inc. Terms and Conditions